C—Side by side
Compare
Up to four peptides. Opinion rows are labeled. Copy the URL to share.
| Field | Epitalon | Pinealon |
|---|---|---|
| Type | Research Only | Research Only |
| Regulatory status | No FDA approval; foreign authorization unverified | No FDA approval; foreign authorization unverified |
| Compounding status | Off Category 2, review pending | Unclear / not listed |
| FDA-approved indications | None | None |
| Categories | Longevity & mitochondrial | Longevity & mitochondrial, Cognitive & mood |
| Claimed uses |
|
|
| Mechanism | A synthetic tetrapeptide investigated for effects on telomerase, cellular aging and pineal melatonin regulation. These mechanistic observations do not establish human lifespan extension. | A Glu-Asp-Arg tripeptide studied for neuronal resistance to hypoxic and oxidative stress. Proposed effects include modulation of antioxidant defenses and excitotoxicity. |
| Evidence level | Small/early human studies | Animal studies mostly |
| Evidence / Hype (opinion) | Evidence Hype | Evidence Hype |
| Momentum (opinion) | Watch | Watch |
| Routes | Injection | — |
| WADA | Verify | Verify |
| Where it stands (opinion) | Limited human melatonin reports accompany mostly preclinical longevity research. FDA retains safety concerns after nomination withdrawal; robust human longevity evidence is absent. | Published evidence is mainly experimental hypoxia and cell research. Established clinical benefit, long-term safety and a US compounding clearance were not verified. |
| Last reviewed | 2026-10-30 | 2026-10-30 |
| News (30d) | 1 | 0 |